Literature DB >> 17410403

Patients at-risk for cost-related medication nonadherence: a review of the literature.

Becky A Briesacher1, Jerry H Gurwitz, Stephen B Soumerai.   

Abstract

OBJECTIVE: Up to 32% of older patients take less medication than prescribed to avoid costs, yet a comprehensive assessment of risk factors for cost-related nonadherence (CRN) is not available. This review examined the empirical literature to identify patient-, medication-, and provider-level factors that influence the relationship between medication adherence and medication costs.
DESIGN: We conducted searches of four databases (MEDLINE, CINAHL, Sciences Citations Index Expanded, and EconLit) from 2001 to 2006 for English-language original studies. Articles were selected if the study included an explicit measure of CRN and reported results on covarying characteristics. MAIN
RESULTS: We found 19 studies with empirical support for concluding that certain patients may be susceptible to CRN: research has established consistent links between medication nonadherence due to costs and financial burden, but also to symptoms of depression and heavy disease burden. Only a handful of studies with limited statistical methods provided evidence on whether patients understand the health risks of CRN or to what extent clinicians influence patients to keep taking medications when faced with cost pressures. No relationship emerged between CRN and polypharmacy.
CONCLUSION: Efforts to reduce cost-related medication nonadherence would benefit from greater study of factors besides the presence of prescription drug coverage. Older patients with chronic diseases and mood disorders are at-risk for CRN even if enrolled in Medicare's new drug benefit.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17410403      PMCID: PMC2219866          DOI: 10.1007/s11606-007-0180-x

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  46 in total

1.  Drug affordability and prescription noncompliance in the United States: 1997-2002.

Authors:  Jae Kennedy; Joseph Coyne; David Sclar
Journal:  Clin Ther       Date:  2004-04       Impact factor: 3.393

2.  Do drug benefits help Medicare beneficiaries afford prescribed drugs?

Authors:  Thomas S Rector; Patricia J Venus
Journal:  Health Aff (Millwood)       Date:  2004 Jul-Aug       Impact factor: 6.301

3.  The findings of the Rand Health Insurance experiment--a response to Welch et al.

Authors:  J P Newhouse; W G Manning; N Duan; C N Morris; E B Keeler; A Leibowitz; M S Marquis; W H Rogers; A R Davies; K N Lohr
Journal:  Med Care       Date:  1987-02       Impact factor: 2.983

4.  Cost-lowering strategies used by medicare beneficiaries who exceed drug benefit caps and have a gap in drug coverage.

Authors:  Chien-Wen Tseng; Robert H Brook; Emmett Keeler; W Neil Steers; Carol M Mangione
Journal:  JAMA       Date:  2004-08-25       Impact factor: 56.272

5.  Payment restrictions for prescription drugs under Medicaid. Effects on therapy, cost, and equity.

Authors:  S B Soumerai; J Avorn; D Ross-Degnan; S Gortmaker
Journal:  N Engl J Med       Date:  1987-08-27       Impact factor: 91.245

6.  Impact of an annual dollar limit or "cap" on prescription drug benefits for Medicare patients.

Authors:  Chien-Wen Tseng; Robert H Brook; Emmett Keeler; Carol M Mangione
Journal:  JAMA       Date:  2003-07-09       Impact factor: 56.272

7.  Cost-related medication underuse among chronically ill adults: the treatments people forgo, how often, and who is at risk.

Authors:  John D Piette; Michele Heisler; Todd H Wagner
Journal:  Am J Public Health       Date:  2004-10       Impact factor: 9.308

8.  Pharmacy benefits and the use of drugs by the chronically ill.

Authors:  Dana P Goldman; Geoffrey F Joyce; Jose J Escarce; Jennifer E Pace; Matthew D Solomon; Marianne Laouri; Pamela B Landsman; Steven M Teutsch
Journal:  JAMA       Date:  2004-05-19       Impact factor: 56.272

9.  Cost-related medication underuse: do patients with chronic illnesses tell their doctors?

Authors:  John D Piette; Michele Heisler; Todd H Wagner
Journal:  Arch Intern Med       Date:  2004-09-13

10.  The health effects of restricting prescription medication use because of cost.

Authors:  Michele Heisler; Kenneth M Langa; Elizabeth L Eby; A Mark Fendrick; Mohammed U Kabeto; John D Piette
Journal:  Med Care       Date:  2004-07       Impact factor: 2.983

View more
  115 in total

1.  The doughnut hole: it's about medication adherence.

Authors:  Christianne L Roumie
Journal:  Ann Intern Med       Date:  2012-06-05       Impact factor: 25.391

Review 2.  Interventions to promote adherence with oral agents.

Authors:  Susan M Schneider; Kimberly Hess; Tracy Gosselin
Journal:  Semin Oncol Nurs       Date:  2011-05       Impact factor: 2.315

Review 3.  Evidence-based strategies for the optimization of pharmacotherapy in older people.

Authors:  Eva Topinková; Jean Pierre Baeyens; Jean-Pierre Michel; Pierre-Olivier Lang
Journal:  Drugs Aging       Date:  2012-06-01       Impact factor: 3.923

4.  Racial and ethnic disparities in cost-related medication non-adherence among cancer survivors.

Authors:  Minjee Lee; Ramzi G Salloum
Journal:  J Cancer Surviv       Date:  2015-11-30       Impact factor: 4.442

5.  Gender differences in cost-related medication non-adherence among cancer survivors.

Authors:  Minjee Lee; M Mahmud Khan
Journal:  J Cancer Surviv       Date:  2015-09-09       Impact factor: 4.442

6.  The effects of financial pressures on adherence and glucose control among racial/ethnically diverse patients with diabetes.

Authors:  Quyen Ngo-Metzger; Dara H Sorkin; John Billimek; Sheldon Greenfield; Sherrie H Kaplan
Journal:  J Gen Intern Med       Date:  2011-10-18       Impact factor: 5.128

7.  Predictors of medication adherence in an urban Latino community with healthcare disparities.

Authors:  Jennifer A Colby; Fei Wang; Jyoti Chhabra; Rafael Pérez-Escamilla
Journal:  J Immigr Minor Health       Date:  2012-08

8.  Impact of a complementary/integrative medicine program on the need for supportive cancer care-related medications.

Authors:  Ilanit Shalom-Sharabi; Noah Samuels; Efraim Lev; Ofer Lavie; Lital Keinan-Boker; Elad Schiff; Eran Ben-Arye
Journal:  Support Care Cancer       Date:  2017-04-22       Impact factor: 3.603

9.  Patterns of borrowing to finance out-of-pocket prescription drug costs in Canada: a descriptive analysis.

Authors:  Ashra Kolhatkar; Lucy Cheng; Steven G Morgan; Laurie J Goldsmith; Irfan A Dhalla; Anne M Holbrook; Michael R Law
Journal:  CMAJ Open       Date:  2018-11-19

10.  Medication affordability gains following Medicare Part D are eroding among elderly with multiple chronic conditions.

Authors:  Huseyin Naci; Stephen B Soumerai; Dennis Ross-Degnan; Fang Zhang; Becky A Briesacher; Jerry H Gurwitz; Jeanne M Madden
Journal:  Health Aff (Millwood)       Date:  2014-08       Impact factor: 6.301

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.